Actively Recruiting
Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2024-12-04
120
Participants Needed
5
Research Sites
105 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
M
Ministry of Health, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
Bronchial fibroscopy (BF) is a routine practice examination in critical care areas. It can be useful either for the diagnosis of the causal pathology of respiratory distress or for the diagnosis of lung infection, sometimes nosocomial. In patients in spontaneous and conscious ventilation, BF are performed vigil after local anesthesia according to the recommendations of the Société de Pneumologie de langue Française. The good tolerance of the examination and its good conduct may require the use of anxiolytics, sedatives or analgesics to limit the traumatic experience of a highly anxiety-provoking examination. Virtual reality (VR) combines a set of paramedical techniques (hypnosis, music therapy, sophrology) and is now a non-drug alternative to improve the tolerance of certain invasive gestures.VR has been shown to reduce pain and anxiety during first pathways placement or digestive endoscopies. To date, there is no evidence of the benefit of VR when performing semi-urgent BF in critical care areas.
CONDITIONS
Official Title
Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (over 18 years of age)
- Hospitalized in a critical care unit (intensive care and intensive care)
- Conscious (Glasgow score >13)
- Spontaneous ventilation
- Requiring the realization of a bronchial fibroscopy
- First bronchial fibroscopy during hospitalization
- Having signed a consent to participate in the study
- Affiliation to social security
You will not qualify if you...
- Non-French-speaking patient
- Protected minors or adults who cannot consent to participate
- People with major neurocognitive impairment
- Patient refusing to participate in the study
- Patient on State medical aid
- Patient under guardianship or curatorship or under judicial protection
- Bronchial fibroscopy for a vital emergency
- Prior inclusion in the study
- Pregnant or breastfeeding women
- Presence of a tracheostomy
- Participation in other intervention research
- Epilepsy
- Visual impairment (blindness) or severe hearing impairment preventing helmet use
- Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia
- Autism spectrum disorders
- Patient sensitive to motion sickness
- Refractory migraine under treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
CHI Aix en Provence
Aix-en-Provence, France, 13100
Actively Recruiting
2
CHU Dijon
Dijon, France, 21079
Actively Recruiting
3
Hôpital Le Kremlin Bicêtre
Le Kremlin-Bicêtre, France, 94270
Withdrawn
4
Hôpital européen Georges Pompidou - AP-HP
Paris, France, 75015
Actively Recruiting
5
Hôpital Foch
Suresnes, France, 92150
Not Yet Recruiting
Research Team
A
Aurélie ZINDJIRDJIAN
CONTACT
Y
Youcef SEKOUR
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here